CompletedPhase 2NCT01941745

Efficacy of Recombinant Human Clara Cell 10 Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome

Studying Bronchopulmonary dysplasia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Tufts Medical Center
Principal Investigator
Jonathan Davis, MD, MD
Tufts Medical Center
Intervention
Half normal saline(drug)
Enrollment
88 enrolled
Eligibility
All sexes
Timeline
20132017

Study locations (3)

Collaborators

Brigham and Women's Hospital · Therabron Therapeutics, Inc. · Baystate Medical Center · Poznan University of Medical Sciences · SP ZOZ Szpital Uniwersytecki w Krakowie Oddizat Neonatologii · Instytut Centrum Zdrowia Matki Polki Klinika Neonatologii

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01941745 on ClinicalTrials.gov

Other trials for Bronchopulmonary dysplasia

Additional recruiting or active studies for the same condition.

See all trials for Bronchopulmonary dysplasia

← Back to all trials